# clm_6EEE9A4C63D1

subject: Bristol-Myers Squibb (/record/bristol-myers-squibb.md)  
predicate: cash_and_equivalents  
value: 12,369,000,000 United States dollar  
valid_from: 2022-03-31  
valid_to: 2022-06-30  
published: 2022-04-29  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_4956C44116CA  
last_updated: 2026-11-08  
cite: AsOf. "Bristol-Myers Squibb cash and equivalents: 12,369,000,000 United States dollar", as of 2022-03-31 (until 2022-06-30). Claim clm_6EEE9A4C63D1, https://asof.is/claim/clm_6EEE9A4C63D1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000114/0000014272-22-000114-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2022, filed 2022-04-29  

## Sources

- https://www.sec.gov/Archives/edgar/data/14272/000001427222000114/0000014272-22-000114-index.htm (primary, SEC EDGAR 10-Q Q1 FY2022, published 2022-04-29)

## Supersedes

- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 13,979,000,000 United States dollar | valid 2021-12-31 to 2022-03-31 | conf 0.95 | superseded | superseded_by [clm_6EEE9A4C63D1](/claim/clm_6EEE9A4C63D1.md) | [clm_A4D1B1BB0C75](/claim/clm_A4D1B1BB0C75.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.